Mineralys Therapeutics Inc (MLYS)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: MLYS Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2024-05-10	2024-05-09	PS Planned sale	Rodman David Malcom Chief Medical Officer Officer	1,000 -0.1% 15.00 100,000 USD	1,000 -0.1%	15.00	100,000 USD
2024-02-14	2024-02-12	B Purchase	Samsara BioCapital GP, LLC Large shareholder	555,555 +12.3% 13.50 7,499,993 USD	555,555 +12.3%	13.50	7,499,993 USD
2023-11-27	2023-11-22	B Purchase	Congleton Jon Chief Executive Officer Executive Director	4,250 +0.4% 5.97 25,356 USD	4,250 +0.4%	5.97	25,356 USD
2023-09-08	2023-09-06	B Purchase	Congleton Jon Chief Executive Officer Executive Director	2,250 +0.2% 12.08 27,180 USD	2,250 +0.2%	12.08	27,180 USD
2023-08-21	2023-08-17	B Purchase	Congleton Jon Chief Executive Officer Executive Director	2,250 +0.2% 12.10 27,225 USD	2,250 +0.2%	12.10	27,225 USD
2023-08-11	2023-08-11	B Purchase	Congleton Jon Chief Executive Officer Executive Director	2,000 +0.2% 12.89 25,780 USD	2,000 +0.2%	12.89	25,780 USD
2023-08-11	2023-08-11	S Sale	Rodman David Malcom Chief Medical Officer Officer	76,182 -100.0% 12.81 975,891 USD	76,182 -100.0%	12.81	975,891 USD
2023-08-11	2023-08-11	S Sale	Rodman David Malcom Chief Medical Officer Officer	80,909 -100.0% 12.81 1,036,444 USD	80,909 -100.0%	12.81	1,036,444 USD
2023-08-11	2023-08-10	S Sale	Rodman David Malcom Chief Medical Officer Officer	74,625 -100.0% 13.16 982,065 USD	74,625 -100.0%	13.16	982,065 USD
2023-02-16	2023-02-14	B Purchase	Slingsby Brian Taylor Non-Executive Director Large shareholder	250,000 +2.8% 16.00 4,000,000 USD	250,000 +2.8%	16.00	4,000,000 USD
2023-02-16	2023-02-14	B Purchase	HBM Healthcare Investments (Cayman) Ltd. Large shareholder	312,500 +10.8% 16.00 5,000,000 USD	312,500 +10.8%	16.00	5,000,000 USD
2023-02-16	2023-02-14	B Purchase	RA CAPITAL MANAGEMENT, L.P. Non-Executive Director	1,118,400 +579.9% 16.00 17,894,400 USD	1,118,400 +579.9%	16.00	17,894,400 USD
2023-02-16	2023-02-14	B Purchase	RA CAPITAL MANAGEMENT, L.P. Non-Executive Director	131,600 +7.6% 16.00 2,105,600 USD	131,600 +7.6%	16.00	2,105,600 USD
2023-02-16	2023-02-14	B Purchase	AKKARAJU SRINIVAS Non-Executive Director Large shareholder	937,500 +26.2% 16.00 15,000,000 USD	937,500 +26.2%	16.00	15,000,000 USD
2023-02-16	2023-02-14	B Purchase	Levy Adam Scott CFO, Chief Bus. Off. and Secy. Officer	6,250 +1.8% 16.00 100,000 USD	6,250 +1.8%	16.00	100,000 USD